ITMO Santé Publique
ITMO Santé Publique
Date de modification : 22/04/2021 | Version : 1 | ID : 73841
| Général | |
| Identification | |
| Nom détaillé | Evaluation of the post-COVID-19 functional status (PCFS) scale as a screening tool for sequelae in patients with COVID-19 hypoxic pulmonary disease |
| Sigle ou acronyme | suivi-COVID |
| Thématiques générales | |
| Domaine médical |
Pneumology |
| Etude en lien avec la Covid-19 |
Yes |
| Pathologie, précisions | sequelae of hypoxic pulmonary disease |
| Déterminants de santé |
Others (specify) |
| Autres, précisions | nothing in particular |
| Mots-clés | functional status scale, Pneumonia |
| Responsable(s) scientifique(s) | |
| Nom du responsable | Eschapasse |
| Prénom | Emmanuel |
| Adresse | HGRL CHU Nantes |
| ESCHAPASSE Emmanuel <Emmanuel.ESCHAPASSE@chu-nantes.fr> | |
| Organisme | Nantes University Hospital CIC |
| Collaborations | |
| Participation à des projets, des réseaux, des consortiums |
No |
| Financements | |
| Financements |
Private |
| Précisions | Pays de la Loire Respiratory Health Research Institute |
| Gouvernance de la base de données | |
| Organisation(s) responsable(s) ou promoteur | Nantes University Hospital |
| Statut de l’organisation |
Secteur Public |
| Existence de comités scientifique ou de pilotage |
No |
| Contact(s) supplémentaire(s) | |
| Nom du contact | Lemarchand |
| Prénom | Patricia |
| Adresse | l'institut du thorax - UMR Inserm 1087/CNRS 6291<br>IRS-UN, 8 quai Moncousu, BP 70721<br>44007 Nantes cedex 1, France |
| patricia.lemarchand@univ-nantes.fr | |
| Laboratoire | Thorax Institute - UMR Inserm 1087/CNRS 6291 |
| Organisme | Inserm |
| Caractéristiques | |
| Type de base de données | |
| Type de base de données |
Others |
| Préciser | medical hospitalisation and follow-up data |
| Base de données issues d'enquêtes, précisions |
Longitudinal study (except cohorts) |
| Origine du recrutement des participants |
A selection of health institutions and services |
| Critère de sélection des participants |
Another treatment or procedure |
| Le recrutement dans la base de données s'effectue dans le cadre d'une étude interventionnelle |
No |
| Informations complémentaires concernant la constitution de l'échantillon |
The population concerned brings together patients aged 18 to 75 years, admitted to Nantes University Hospital for pulmonary disease requiring supplemental oxygen therapy (known as hypoxic pulmonary disease) attributed to SARS-CoV-2 based on a positive PCR or chest CT scan criteria, having completed the PCFS and mMRC questionnaires.
These patients will constitute the Nantes post-COVID-19 follow-up cohort. As part of their management, they will be offered routine follow-up at 3 months, either as a pulmonology appointment if standard hospitalisation was required, or in the outpatient clinic setting allowing a wider panel of tests to be performed, if admission to an intensive care unit was warranted due to the initial severity of the infection, with or without invasive ventilation. More than 700 patients tested positive for SARS-CoV-2 at Nantes University Hospital between February and June 2020. Approximately one hundred of these patients fulfil the criteria for age and severity of pulmonary disease, and are therefore eligible for this follow-up. |
| Objectif de la base de données | |
| Objectif principal | The primary objective of this project is to propose a French translation and assess the post-COVID-19 functional status (PCFS) scale as a screening tool for respiratory sequelae in patients with COVID-19 hypoxic pulmonary disease after 3 months in the Nantes COVID-19 hypoxic pulmonary disease cohort, attending an appointment at Nantes University Hospital. The primary endpoint will be to assess the Spearman correlation between the PCFS scale and the mMRC (modified Medical Research Council) scale. |
| Critères d'inclusion |
Adult patient, aged under 75 years, having been admitted to Nantes University Hospital for hypoxic pulmonary disease, defined by the need for supplemental oxygen therapy for at least 24 hours, associated with a diagnosis of SARS-CoV-2 infection confirmed by PCR or CT scan lesions consistent with infection in the event of a negative PCR, attending the 3 month follow-up visit, and having completed the PCFS and mMRC questionnaires.
|
| Type de population | |
| Age |
Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population concernée |
Sick population |
| Pathologie | J12 - Viral pneumonia, not elsewhere classified |
| Sexe |
Male Woman |
| Champ géographique |
Regional |
| Régions concernées par la base de données |
Pays de la Loire |
| Collecte | |
| Dates | |
| Année du premier recueil | 2020 |
| Année du dernier recueil | 2021 |
| Taille de la base de données | |
| Taille de la base de données (en nombre d'individus) |
< 500 individuals |
| Données | |
| Activité de la base |
Current data collection |
| Type de données recueillies |
Clinical data Declarative data Paraclinical data Biological data |
| Données cliniques, précisions |
Direct physical measures Medical registration |
| Données déclaratives, précisions |
Paper self-questionnaire |
| Modalités | |
| Suivi des participants |
No |
| Pathologie suivies | |
| Appariement avec des sources administratives |
No |
| Valorisation et accès | |
| Valorisation et accès | |
| Accès |
| A PROPOS | CATALOGUE | RESSOURCES | LIENS UTILES
|  Ce site respecte les principes de la charte HONcode. Vérifiez ici. |
8 rue de la Croix Jarry 75013 Paris Tél: 01 44 23 67 47 |
Partenaires - F.A.Q. - Contact - Plan du site - Mentions légales - Administration - PEF-HD - Mis à jour le 15 décembre 2020 - Version 4.10.05
